Prognostic significance of ST segment early after resolution ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST segment monitoring substudy

Journal of the American College of Cardiology

Volumn 31, Issue 4, 1998, Pages 783-789

  Langer, Anatoly ^a   Krucoff, Mitchell W ^b   Klootwijk, Peter ^c   Simoons, Maarten L ^c   Granger, Christopher B ^b   Barr, Aiala ^a   Califf, Robert M ^b   Armstrong, Paul W ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; STREPTOKINASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY DIAMETER; ARTICLE; DIAGNOSTIC VALUE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR; ST SEGMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TIME;

ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STREPTOKINASE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032521464     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0735-1097(97)00544-5     Document Type: Article

References (51)

1. 1. Hackett D, Davies G, Chiercha S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-9.
2. 2. Krucoff MW, Wagner NB, Pope JE, et al. The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent reocclusion. Am J Cardiol 1990;65:143-8.
3. 3. Clemmensen P, Ohman M, Sevilla DC, et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol 1990;66:1407-11.
4. 4. Dellborg M, Topol EJ, Swedberg K. Dynamic QRS complex and ST-segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J 1991;122:943-8.
5. 5. Dellborg M, Riha M, Swedberg K. Dynamic QRS complex and ST segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. Am J Cardiol 1991;67:343-9.
6. 6. Krucoff MW, Cross MA, Pope JE, et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 1993;71:145-51.
7. 7. Shah PK, Cercek B, Lew AS, Ganz W. Angiographic validation of bedside markers of perfusion. J Am Coll Cardiol 1993;21:55-61.
8. 8. Kondo M, Tamura K, Tanio H, Shimono Y. Is ST segment reelevation associated with reperfusion an indicator of marked myocardial damage after thrombolysis? J Am Coll Cardiol 1993;21:62-7.
9. 9. Langer A, Krucoff MW, Klootwijk P, et al, for the GUSTO Investigators. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST Segment Monitoring Study. J Am Coll Cardiol 1995;25:1552-7.
10. 10. von Arnim T, Gerbig HW, Krawietz W, Hofling B. Prognostic implications of transient - predominantly silent - ischaemia in patients with unstable angina pectoris. Eur Heart J 1988;9:435-40.
11. 11. Nademanee K, Intarachot V, Josephson MA, Rieders D, Mody FV, Singh BN. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987;10:1-9.
12. 12. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2-year follow-up of unstable angina. J Am Coll Cardiol 1987;10:756-60.
13. 13. Johnson SM, Mauritson DR, Winniford MD, et al. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J 1982;103:4-12.
14. 14. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-1502.
15. 15. Langer A, Singh N, Freeman MR, Tibshirani R, Armstrong PW. Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients. Can J Cardiol 1995;11:117-22.
16. 16. Ouyang P, Chandra NC, Gottlieb SO. Frequency and importance of silent myocardial ischemia identified with ambulatory electrocardiographic monitoring in the early in-hospital period after acute myocardial infarction. Am J Cardiol 1990;65:267-70.
17. 17. Gottlieb SO, Gottlieb SH, Achuff SE, et al. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 1988;259:1030-5.
18. 18. Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988;62:661-4.
19. 19. Langer A, Minkowitz J, Dorian P, et al, for the Tissue Plasminogen Activator: Toronto (T-PAT) Study Group. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. J Am Coll Cardiol 1992;20:1313-7.
20. 20. Solimene MC, Ramires JA, Gruppi CJ, et al. Prognostic significance of silent myocardial ischemia after a first uncomplicated myocardial infarction. Int J Cardiol 1993;38:41-7.
21. 21. Silva P, Galli M, Campolo L, for the IRES (Ischemia Residua) Study Group. Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. Am J Cardiol 1993;71:1142-7.
22. 22. Gill JB, Cairns JA, Roberts RS, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996;334:65-70.
23. 23. Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: Outcome according to clinical presentation. J Am Coll Cardiol 1992;19:1659-63.
24. 24. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q wave myocardial infarction in predicting outcome. Am J Cardiol 1991;67:1368-73.
25. 25. Langer A, Freeman MR, Armstrong PW. Relation to angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris. Am J Cardiol 1990;66:1381-2.
26. 26. Serneri GGN, Boddi M, Arata L, et al. Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling. Circulation 1993;87: 1928-37.
27. 27. Gurfinkel E, Altman R, Scazziota A, Rouvier J, Mautner B. Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina. Br Heart J 1994;71:151-5.
28. 28. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
29. 29. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
30. 30. Krucoff MW, Green CL, Langer A, et al. Global Utilization of Streptokinase and TPA for Occluded Arteries (GUSTO) ECG Monitoring Substudy. J Electrocardiol 1994;26:249-55.
31. 31. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
32. 32. Pepine CJ. Is silent ischemia a treatable risk factor in patients with angina pectoris? Circulation 1990;82 Suppl II:II-135-142.
33. 33. Fernandez AR, Sequeira RF, Chakko S, et al. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction. J Am Coll Cardiol 1995;26:675-83.
34. 34. Timmis GC. ST segment analysis for determining the dynamic status of reperfusion therapy. J Am Coll Cardiol 1995;25:684-7.
35. 35. Klootwijk P, Langer A, Meij S, et al. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST-segment monitoring in the GUSTO-I trial. Eur Heart J 1996;17:689-98.
36. 36. Fox KM, Jonathan A, Selwin A. Significant of exercise-induced ST-segment elevation in patients with previoius myocardial infarction. Br Heart J 1983;49:15-9.
37. 37. Coma-Canella I, Gomez MV, Terol I, Rodrigo F, Castro JM. Radionuclide studies in patients with stress-induced ST-segment elevation after acute myocardial infarction. Am Heart J 1994;128:459-65.
38. 38. Elhendy A, Fioretti PM. Stress-induced ST-segment elevation after a recent myocardial infarction: myocardial necrosis, viability or both? Eur Heart J 1996;17:975-7.
39. 39. Dorian P, Langer A, Morgan C, Casella L, Harris L, Armstrong P. Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Am J Cardiol 1994;74:419-23.
40. 40. Ohman EM, Armstrong PW, Christenson RH, et al., for the GUSTO-IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996;335:1333-41.
41. 41. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
42. 42. Topol EJ, Califf RM, George BS, et al., and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987; 317:581-8.
43. 43. Guerci AD, Gerstenblith G, Brinker JA, et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med 1987;317:1613-8.
44. 44. Simoons ML, Betriu A, Col J, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;1:197-203.
45. 45. The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 1988;260:2849-58.
46. 46. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
47. 47. Rogers WJ, Baim DS, Gore JM, et al., for the TIMI II-A Investigators. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II-A trial. Circulation 1990;81: 1457-76.
48. 48. Barbash GI, Roth A, Hod H, et al. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:538-45.
49. 49. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT Trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ 1991;302: 555-60.
50. 50. Topol E, Califf RM, Vandormael M, et al., and the Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85:2090-9.
51. 51. Ellis SG, Mooney MR, George BS, et al., for the Treatment of Post-Thrombolytic Stenosis (TOPS) Study Group. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenosis after thrombolytic treatment of myocardial infarction. Circulation 1992;86:1400-6.